Antibodies
27 August 2014
Green Cross Initiates Phase II Trial of Investigational Recombinant Hepatitis B Immune Globulin20 August 2014
Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody18 August 2014
Initiation of Phase 3 Trial of CHS-0214 (Investigational Etanercept Biosimilar) in Japan (RApsody)15 August 2014
FDA approves Roche’s Avastin plus chemotherapy for treatment of advanced cervical cancer14 August 2014
Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy13 August 2014
Celltrion files for US FDA approval of Remsima®8 August 2014
Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy7 August 2014
Emergent BioSolutions Submits Biologics License Application to FDA for Anthrax Immune Globulin Intravenous (Human)1 August 2014
Initiation of Multiple Ascending Dose Phase 1 Study of PRX002 in Patients With Parkinson’s Disease1 August 2014
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency31 July 2014
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA SubmissionNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports